Italy· 043658032
ABASAGLAR*5 cartucce SC 100 U/ml 3 ml
A medicinal product containing insulina glargine, registered in Italy by ELI LILLY NEDERLAND BV, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Insulina glargine
- Manufacturer
- ELI LILLY NEDERLAND BV
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic043658032ABASAGLAR*5 cartucce SC 100 U/ml 3 mlEUR 60.69
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulina glargine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABASAGLAREli Lilly Nederland B.V., Utrecht
- United KingdomAbasaglar 100units/ml solution for injection 3ml cartridgesEli Lilly and Company Ltd
- United StatesBASAGLAREli Lilly and Company
- BelgiumAbasaglar 100 U/mlEli Lilly Nederland
- FinlandABASAGLAREli Lilly Nederland B.V.
- SpainABASAGLAR 100 UNIDADES/ML KWIKPEN SOLUCION INYECTABLE EN PLUMA PRECARGADAEli Lilly Nederland B.V.
- IrelandABASAGLAR 100 units/mL solution for injection in a cartridgeEli Lilly Nederland B.V.
- SwedenABASAGLAR 100 enheter/ml Injektionsvätska, lösning i cylinderampullEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Abasaglar, Abasaglar Kwikpen
- Liechtenstein · Abasaglar, Abasaglar Kwikpen
- Norway · Lantus, Lantus Solostar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f907a1cc-ccf6-45d4-bdeb-48a70e7622bd GET /v1/drugs/f907a1cc-ccf6-45d4-bdeb-48a70e7622bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 60.69,
"source": "aifa",
"currency": "EUR",
"strength": "INSULINA GLARGINE 100U/ML 3ML 5 UNITA' USO PARENTERALE",
"substance": "Insulina glargine",
"equivalence_group": "N4B",
"transparency_flag": null
}See everything about insulina glargine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.